4.1 Article

Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

The Significance of Normal Pretreatment Levels of CA125 (< 35 U/mL) in Epithelial Ovarian Carcinoma

Joseph Menczer et al.

RAMBAM MAIMONIDES MEDICAL JOURNAL (2015)

Article Oncology

Cancer Statistics, 2014

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2014)

Review Oncology

Epigenetic biomarkers in epithelial ovarian cancer

Brian S. Gloss et al.

CANCER LETTERS (2014)

Editorial Material Oncology

2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer Clinical comment

David G. Mutch et al.

GYNECOLOGIC ONCOLOGY (2014)

Article Oncology

A Prospective Study of Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) and Risk of Colorectal Cancer

Raaj S. Mehta et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Review Biochemistry & Molecular Biology

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Mildred Felder et al.

MOLECULAR CANCER (2014)

Review Pharmacology & Pharmacy

The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer

Xingya Wang et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Article Obstetrics & Gynecology

Ovarian Cancer Screening

John R. van Nagell et al.

CLINICAL OBSTETRICS AND GYNECOLOGY (2012)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Oncology

Personalizing CA125 Levels for Ovarian Cancer Screening

Oliver Dorigo et al.

CANCER PREVENTION RESEARCH (2011)

Review Oncology

Rethinking ovarian cancer: recommendations for improving outcomes

Sebastian Vaughan et al.

NATURE REVIEWS CANCER (2011)

Article Oncology

Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer

Anne Cathrine Staff et al.

GYNECOLOGIC ONCOLOGY (2010)

Review Obstetrics & Gynecology

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

Vladimir Nossov et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)

Article Oncology

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

MJ Duffy et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)